The DOI matches its Crossref record.
Differential activation of p44 mapk (ERK1) by α-thrombin and thrombin-receptor peptide agonist
Open accessAbstract
alpha-Thrombin (thrombin), a potent mitogen for CCL39 hamster lung fibroblasts, stimulates phosphoinositide-specific phospholipase C (PI-PLC) and inhibits adenylate cyclase via cleavage of a specific G-protein-coupled receptor (TH-R), recently cloned from human and hamster cells. This action can be entirely mimicked by the synthetic peptide SFFLRNP, referred to here as TMP (thrombin-mimicking peptide). TMP corresponds to the first seven amino acids of the new N-terminus generated by thrombin cleavage of the hamster TH-R. Although thrombin and TMP apparently generate identical early transmembrane signals, only thrombin is mitogenic on its own. TMP needs to be associated with fibroblast growth factor (FGF), a tyrosine kinase-activating growth factor, to induce cell-cycle re-entry. Here, we have examined the early and late phase of p44 MAP kinase (p44mapk) activation in G0-arrested CCL39 cells after stimulation by thrombin, TMP, FGF or TMP+FGF. We found that: (i) both thrombin and TMP rapidly activate p44mapk in a dose-dependent manner with maximum activation at around 5 min, (ii) after the initial burst of activation, a second and long-lasting wave of activation is observed in response to thrombin (10-100 nM) but not to TMP (up to 300 microM), (iii) FGF alone (25 ng/ml), like thrombin, rapidly and persistently activates p44mapk (20-fold at 5 min and about 3-fold after 2 h), (iv) TMP added together with FGF strongly potentiates the second and sustained phase of p44mapk activation. From these results we propose that: (1) thrombin-induced mitogenesis is mediated only in part by the TH-R recently cloned and (2) activation of p44mapk, in particular the long-lasting phase that correlates with DNA synthesis, is an obligatory event for cell-cycle re-entry.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Signal Transduction through MAP Kinase Cascades
(1998) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60765-4 · Cited by 1,759
Molecular interpretation of ERK signal duration by immediate early gene products
Murphy, L. O., Smith, S., Chen, R.-H., Fingar, D. C., & Blenis, J. (2002) · Nature Cell Biology · doi:10.1038/ncb822 · Cited by 929
Proteinase-activated receptors: novel mechanisms of signaling by serine proteases
Déry, O., Corvera, C. U., Steinhoff, M., & Bunnett, N. W. (1998) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1998.274.6.c1429 · Cited by 779
ERK implication in cell cycle regulation
Chambard, J.-C., Lefloch, R., Pouysségur, J., & Lenormand, P. (2007) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2006.11.010 · Cited by 750
Self-citationLenormand, P., Sardet, C., Pagès, G., L'Allemain, G., Brunet, A., & Pouysségur, J. (1993) · The Journal of cell biology · doi:10.1083/jcb.122.5.1079 · Cited by 661
Self-citationSuppression of SHP-2 and ERK Signalling Promotes Self-Renewal of Mouse Embryonic Stem Cells
Burdon, T., Stracey, C., Chambers, I., Nichols, J., & Smith, A. (1999) · Developmental Biology · doi:10.1006/dbio.1999.9265 · Cited by 585
WEBER, J. D., RABEN, D. M., PHILLIPS, P. J., & BALDASSARE, J. J. (1997) · Biochemical Journal · doi:10.1042/bj3260061 · Cited by 406
Hormonal regulation, pharmacology, and membrane sorting of vertebrate Na+/H+ exchanger isoforms
Noel, J., & Pouyssegur, J. (1995) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1995.268.2.c283 · Cited by 396
Bogoyevitch, M. A., Glennon, P. E., Andersson, M. B., Clerk, A., Lazou, A., Marshall, C. J., Parker, P. J., & Sugden, P. H. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)42228-9 · Cited by 388
Structure, function and pathophysiology of protease activated receptors
Adams, M. N., Ramachandran, R., Yau, M.-K., Suen, J. Y., Fairlie, D. P., Hollenberg, M. D., & Hooper, J. D. (2011) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.01.003 · Cited by 370
Mitogenic signaling via G protein-coupled receptors
van BIESEN, T., LUTTRELL, L. M., HAWES, B. E., & LEFKOWITZ, R. J. (1996) · Endocrine Reviews · doi:10.1210/edrv-17-6-698 · Cited by 361
Cellular consequences of thrombin-receptor activation
GRAND, R. J. A., TURNELL, A. S., & GRABHAM, P. W. (1996) · Biochemical Journal · doi:10.1042/bj3130353 · Cited by 334
Ebisuya, M., Kondoh, K., & Nishida, E. (2005) · Journal of Cell Science · doi:10.1242/jcs.02505 · Cited by 331
Cyclic AMP activates the mitogen-activated protein kinase cascade in PC12 cells.
Frödin, M., Peraldi, P., & Van Obberghen, E. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)37589-0 · Cited by 320
Self-citationHotokezaka, H., Sakai, E., Kanaoka, K., Saito, K., Matsuo, K.-I., Kitaura, H., Yoshida, N., & Nakayama, K. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m208284200 · Cited by 316
Proteinases and signalling: pathophysiological and therapeutic implications via PARs and more
Ramachandran, R., & Hollenberg, M. D. (2008) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707507 · Cited by 305
Pleiotropic Coupling of G Protein-coupled Receptors to the Mitogen-activated Protein Kinase Cascade
Della Rocca, G. J., Maudsley, S., Daaka, Y., Lefkowitz, R. J., & Luttrell, L. M. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.20.13978 · Cited by 260
Metadata
- Authors
- Vouret-Craviari, V, Van Obberghen-Schilling, E., Scimeca, J. C., Van Obberghen, E., & Pouysségur, J.
- Venue
- Biochemical Journal
- Publisher
- Portland Press Ltd.
- Published
- 1993-01-01
- Volume
- 289
- Issue
- 1
- Pages
- 209-214
- ISSN
- 0264-6021 (ISSN-L)
- 1470-8728
- OpenAlex
- W2211131169
- Cited by
- 160
- References
- 0
- FWCI
- 11.93
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.